Ocugen Inc
Healthcare · EUR · F
Price
€1.175
Cap
€511.16M
Earnings
—
30d Trend
-22.2%
91% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 51×Macro 0.99 (−1%)=50
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Medium-term outlook is neutral — no clear directional thesis
BRAIN47'S ASSESSMENT
I rate Ocugen Inc at 50/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 79/100. I classify this as a speculative position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
-16.1%
3 MONTHS
-22.5%
12 MONTHS
+69.0%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Medium-term outlook is neutral — no clear directional thesis. Momentum (79) and Quality (49) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 91%. I classify this as a speculative position — elevated volatility at 91% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.